BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1336913)

  • 1. [The EBNA2 coding region in the viral genome of Epstein-Barr virus (EBV)-positive cases of Hodgkin's disease].
    Borisch B; Telenti A; Hennig I; Marchesi F; Audouin J; Diebold J; Pallesen G
    Verh Dtsch Ges Pathol; 1992; 76():181-4. PubMed ID: 1336913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
    Delsol G; Brousset P; Chittal S; Rigal-Huguet F
    Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas].
    Herbst H; Dallenbach F; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Jautzke G; Müller-Lantzsch N; Stein H
    Verh Dtsch Ges Pathol; 1991; 75():175-8. PubMed ID: 1724825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-existence of the A and B types of Epstein-Barr virus DNA in lymph node biopsies from Algerian patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Bouzid M; Belkaid MI; Colonna P; Bouguermouh AM; Ooka T
    Leukemia; 1993 Sep; 7(9):1451-5. PubMed ID: 8396698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients.
    Audouin J; Diebold J; Pallesen G
    J Pathol; 1992 Aug; 167(4):381-4. PubMed ID: 1328576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
    Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
    J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
    Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
    Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas.
    Kanavaros P; Jiwa NM; de Bruin PC; van der Valk P; Noorduyn LA; van Heerde P; Gordijn R; Horstman A; Mullink R; Willemze R
    J Pathol; 1992 Nov; 168(3):307-15. PubMed ID: 1335046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epstein-Barr virus and malignant lymphomas--studies on incidence and localization of viral DNA].
    Herbst H; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Bergholz M; Kneba M; Krieger G; Stein H
    Verh Dtsch Ges Pathol; 1990; 74():386-9. PubMed ID: 1708622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of Epstein-Barr virus genome on patient survival in Hodgkin's disease].
    Niedermeyer H; Fellbaum C; Hansmann ML; Kraus I; Alavaikko MJ; Busch R; Pütz B; Fischer R; Höfler H
    Verh Dtsch Ges Pathol; 1992; 76():173-6. PubMed ID: 1283253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
    Pinkus GS; Lones M; Shintaku IP; Said JW
    Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells.
    Pallesen G; Hamilton-Dutoit SJ; Rowe M; Lisse I; Ralfkiaer E; Sandvej K; Young LS
    J Pathol; 1991 Dec; 165(4):289-99. PubMed ID: 1664459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent detection of Epstein-Barr viral deoxyribonucleic acid and absence of cytomegalovirus deoxyribonucleic acid in Hodgkin's disease and acquired immunodeficiency syndrome-related Hodgkin's disease.
    Samoszuk M; Ravel J
    Lab Invest; 1991 Dec; 65(6):631-6. PubMed ID: 1661351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease?
    Khan G; Gupta RK; Coates PJ; Slavin G
    Am J Pathol; 1993 Nov; 143(5):1270-4. PubMed ID: 8238244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.